Vision
Tzamal Biopharma’s vision can be summarized as “Patients’ Health and Life Quality at Prime.. We are devoted to provide patients with innovative, cost effective top-quality pharmaceutical products, taking part in offering added value to both patients physicians, as well as other business partners.
Mission Statement
To provide hospitals and health care services providers (including sick funds) across the country with top-quality pharmaceutical products, tailored to specific medical fields.
To facilitate and expedite the adoption and proper use of our company’s products.
To maintain a leadership position in the Israeli medical and pharmaceutical markets.
In-licensing, Distribution, and Commercial Collaboration
Tzamal Biopharma has long been regarded a partner of choice for international pharmaceutical companies looking to start or expend their business activity in the Israeli market.
Tzamal Biopharma constantly seeks and explores in-licensing, distribution, and acquisition opportunities as well as other types of commercial collaborations aimed at marketing and distribution of pharma products in Israel, whether these are at an advanced stage of clinical development or already commercially available.
The Company owes its leadership position in the Israeli pharmaceutical market to three main prescription-drug categories: (1) Innovative prescription drugs and biological products for hospital use; (2) Innovative prescription drugs for community use; and (3) Selected generic drugs for both hospital and community use.
With years of marketing and sales experience, we have the knowledge to conduct extensive market surveys providing potential partners with accurate medical and commercial insights to support decision making.
We are always on the lookout for new opportunities in its current areas of clinical expertise as well as in new, promising therapeutic areas.
Our Advantages
- While being a medium-size pharmaceutical marketing company, we do possess in-depth knowledge of the Israeli pharmaceutical market, likewise of the regulatory affairs required by the Israeli Ministry of Health [MOH].
- We are a marketing-oriented, fast-reacting, and success-driven constantly on the lookout for innovative pharmaceutical products available for licensing and/or investment opportunities.
- Our Company is among the few domestic providers of choice for hospitals and prominent health care organizations (sick funds) – which expedites medical drugs sales facilitating and introducing new drugs into the market.
- Our mode of operation is flexible and adaptive, capable of tailoring our services to diversified market segments, such as hospitals and local communities.
- Our Products Managers are fully committed to promoting our carefully selected product portfolio, - as opposed to multinationals operating in our home market, which mostly promote and sell their own developed products.
- Of no less importance, we have gained vast experience working with pharmaceutical international companies adding value and complementing their self-marketing and promotional activities.
- Our Company will conduct market research and analyses at your request to support project and investment-related decision making before registrations, or prior to the conduct of potential clinical studies.
The Importance of the Israeli Medical Market
Israel is ranked among the world top countries for technological innovation and entrepreneurship likewise for its creative, skillful, and motivated technological workforce, resulting among other reasons to drive leading executives from different geographies to enter the Israeli market and develop their business in the country.
This is the case for hundreds of multinational corporations, which have already established domestic business operations in our country, it is particularly evident for large international pharmaceutical companies, benefiting from Israel’s advanced national healthcare services,comprehensive medical insurance programs, and large scale life sciences research at academic institutes leading to rapid growth in the local market.
